- Semax clears your blood in 2 minutes. A 1996 double-blind trial found cognitive effects lasted 20-24 hours from a single dose. Once the delivery mechanism clicks, the once-daily dosing protocol makes sense.
- The 0.1% vs 1% concentration difference is a 10x dose error. Most 'Semax did nothing' and 'Semax made me anxious' reports trace to this single label mistake, from opposite directions.
- Clinical stroke trials used 12,000-18,000 mcg per day. Nootropic doses are 200-600 mcg per day. These are not the same protocol and should never be confused.
- Published protocols start at 100-200 mcg daily with the 0.1% solution and step up to 400-600 mcg, run 10-14 days on and 10-14 days off, following the Russian clinical template.
- Two things set how much room Semax has to work: how much of the brain growth factor BDNF you release under load, and how fast your brain clears dopamine. Both are partly inherited, and both point to which end of the dose range is the sensible place to start.
Semax disappears from your bloodstream in roughly 2 minutes. A 1996 double-blind, placebo-controlled trial in healthy volunteers measured cognitive effects lasting 20 to 24 hours from a single dose. Both numbers are accurate. The reason they coexist is the most important thing to understand before calculating your first dose, and it explains why dosing instructions that say "three times daily" are almost always wrong.
This guide covers the full Semax dosage chart by concentration, the calculation error behind most failed protocols, and what the Russian clinical data actually shows versus what works for cognitive enhancement.
Semax survives about 2 minutes in the blood before enzymes there cut it apart. Measured cognitive effect duration in Kaplan et al. 1996: 20 to 24 hours from a single intranasal dose. The peptide reaches your brain along the smell nerve within minutes, bypassing the blood entirely. It does not need to stay in your bloodstream to keep working.
Semax is a synthetic seven-amino-acid fragment modelled on part of the stress hormone ACTH, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the early 1980s. Russia approved it for clinical use in ischemic stroke, cognitive disorders, and optic nerve disease, and has maintained it on its List of Vital and Essential Drugs since 2011. The US FDA scheduled a formal compounding review for July 2026 that could change its legal status for licensed US pharmacies.
The mechanism that matters for cognitive use is a rise in BDNF, the growth factor neurons use to build new connections. A single dose switches on the genes for BDNF and a related nerve growth factor in the memory centre of the brain within hours. A 2018 study by Gusev and colleagues in Zh Nevrol Psikhiatr measured higher BDNF in the blood of 110 post-stroke patients on 6,000 mcg daily. Semax also nudges dopamine release in the brain's motivation circuits within the first 1 to 4 hours, which is why focus and drive register sooner than any structural benefit could.
BDNF is the growth factor your neurons use to form new connections and keep adapting under load. Exercise and fasting raise it too, but over days to weeks. Semax switches the BDNF gene on within hours of a single dose. The effect is not permanent. It is a temporary dial-up, and the dial drifts back down with continuous use, which is the argument for cycling.
Semax Dosage Chart: 0.1% vs 1% Side by Side
The most important framing before this table: the dose for cognitive enhancement in healthy adults and the dose for acute ischemic stroke treatment are separated by a factor of 20 to 30. They come from completely different research contexts with completely different risk profiles. Know which category you are working in before you calculate anything.
| Use case | Solution | Per spray | Daily dose range | Typical cycle |
|---|---|---|---|---|
| Cognitive enhancement, beginner | 0.1% (1 mg/mL) | 100 mcg | 100-200 mcg | 5-7 days |
| Cognitive enhancement, standard | 0.1% (1 mg/mL) | 100 mcg | 200-600 mcg | 10-14 days |
| Cognitive enhancement, upper range | 0.1% (1 mg/mL) | 100 mcg | 600-1,000 mcg | 10-14 days |
| Acute ischemic stroke (Russian clinical) | 1% (10 mg/mL) | 1,000 mcg | 12,000-18,000 mcg | 5-10 days (inpatient) |
| Post-stroke rehabilitation | 1% (supervised) | 1,000 mcg | 6,000 mcg | 2 x 10-day courses |
Using the 0.1% solution for cognitive enhancement
The 0.1% solution delivers 1 mg of Semax per mL. A standard nasal spray pump actuates 0.1 mL per spray, giving you 100 mcg per actuation. Russian commercial dropper bottles (Peptogen brand) deliver approximately 50 mcg per drop. Three drops per nostril from a Russian dropper equals roughly 300 mcg per session.
The Kaplan 1996 trial used 0.25 to 1.0 mg in healthy adults, which maps to 2 to 10 sprays of a 0.1% pump formulation per day. Most people find 200 to 400 mcg (2 to 4 sprays) as the practical sweet spot, with effects peaking within 30 to 60 minutes and lasting most of the day from a single morning dose.
Using the 1% solution: clinical only
The 1% solution delivers 10 mg per mL, giving 1,000 mcg per standard spray. This is the concentration used in Russian stroke trials at 12 to 18 mg per day total. These are supervised inpatient protocols for acute neurological injury. If you ordered the 1% solution thinking it would be "stronger" for focus or memory, the next section explains why that reasoning breaks down badly in practice.
Why Confusing 0.1% and 1% Is a 10x Dosing Error
The concentration difference between 0.1% and 1% Semax. A user following a "2 sprays per day" protocol written for the 0.1% solution who applies it to a 1% bottle takes 2,000 mcg instead of 200 mcg. This single error accounts for the large majority of "Semax made me anxious and wired" reports, and a meaningful fraction of "Semax did absolutely nothing" reports when the error runs in reverse.
The two products look nearly identical in a bottle. Labels are sometimes ambiguous. Many protocols in circulation do not specify which concentration they were written for. The math consequence of confusing them is severe, and it runs in both directions.
0.1% Semax
1 mg per mL
100 mcg per pump spray
50 mcg per dropper drop
Standard cognitive dose: 200-600 mcg/day
2-6 sprays per day
1% Semax
10 mg per mL
1,000 mcg per pump spray
500 mcg per dropper drop
Stroke trial dose: 12,000-18,000 mcg/day
Not for cognitive use
Here is the pattern behind most "Semax does nothing" complaints: a user buys the 0.1% bottle, reads a community protocol that was actually written for 1%, and takes one-tenth of what they expected. No effect. They conclude the peptide is overhyped. Flip the error: a user gets the 1% bottle, follows "2-3 drops per nostril" instructions from a 0.1% source, and takes 10x the intended dose. Anxiety, racing heart, and disrupted sleep follow. They conclude Semax is poorly tolerated.
Check the label. Calculate the mcg per spray based on your actual concentration. Every time, before every batch.
What 30 Years of Russian Trials Actually Dosed
A single intranasal dose of 0.25 to 1.0 mg Semax improved memory test accuracy to 71 percent in healthy male volunteers versus 41 percent in the placebo group. Cognitive and electrophysiological effects were measured for 20 to 24 hours post-administration in a double-blind, placebo-controlled crossover design.
Kaplan et al., Neuroscience Research Communications, 1996;19:115-123 (not indexed in PubMed)
This is the foundational human trial. It established three things that matter for cognitive use. First, Semax produces measurable cognitive effects in healthy adults at doses that translate to 2 to 10 sprays of a 0.1% formulation per day. Second, the effect lasts roughly 720 times longer than the peptide survives in the blood, which fits delivery straight up the smell nerve into the brain rather than through the bloodstream. Third, tolerability across all tested doses was clean: no serious adverse events, with only mild nasal irritation in some subjects.
The stroke literature pushed doses into a completely different range. Gusev et al. 1997 ran the registration trial for Russia's stroke indication: 30 acute stroke patients received 12 mg per day for moderate strokes and 18 mg per day for severe strokes, using the 1% solution within 24 hours of onset for 5 to 10 days. Neurological deficit scores improved at days 14 and 28. Most of the Russian stroke work sits in journals PubMed does not index, so anyone quoting a pooled effect size across those trials is quoting something you cannot go and read. Treat the stroke literature as the reason the high-dose protocols exist, not as a measured number you can carry over.
Both bodies of research are real. They are not describing the same use case, or even the same order of magnitude of dosing. The cognitive enhancement trial used 0.25 to 1 mg. The stroke trials used 12 to 18 mg under hospital supervision. The gap between them is not a dosing ladder you should climb independently.
How Long Should You Actually Cycle Semax?
Russian clinical protocols ran Semax in structured courses: 5 to 14 days on, followed by a rest period. The post-stroke rehabilitation data from Gusev et al. 2018 (110 patients, PMID 29798983) used two 10-day courses separated by a 20-day interval. That structure carried over into community practice as the default cycling approach.
Nobody has published data on whether Semax loses potency with daily use. It does not lock onto one receptor that gets switched off by constant stimulation, the way growth hormone peptides do. The working assumption behind cycling is that the BDNF response settles back toward baseline under continuous dosing, so the effect fades around week 2. That is an assumption, not a measurement.
| Protocol type | On period | Off period | Basis |
|---|---|---|---|
| First use | 5-7 days | 5-7 days minimum | Community consensus |
| Standard cognitive protocol | 10-14 days | 10-14 days | Adapted from Russian clinical template |
| Russian stroke rehabilitation | 2 x 10-day courses | 20 days between courses | Gusev et al. 2018 |
The most common cycling mistake is continuous use past 14 days without a break. Users who report "the Semax effect faded at 2 weeks" are describing this normalization, not product failure or tolerance in the pharmacological sense. A 2-week break typically restores the initial response level. If you want to understand whether the stimulating or calming direction is what your situation actually calls for, the Semax vs Selank comparison covers that decision in detail.
Why the same dose feels sharp for one person and blank for another
Semax works along two routes: it raises BDNF, and it makes dopamine easier to release. How much room it has on each route depends partly on where your own biology starts, and that starting point is partly inherited.
On the BDNF side, the relevant variant is Val66Met in the BDNF gene. Met carriers release less BDNF when learning or under stress than Val/Val carriers do. Nobody has published a reliable figure for how much less, so treat it as a direction rather than a percentage. The lower the baseline, the more room a BDNF-raising compound has, which is why Met carriers more often report clear effects at the low end of the dose range. The brain-fog peptide guide covers this BDNF variant in more detail if you want to compare it against other options.
On the dopamine side, the relevant gene is COMT, the enzyme that clears dopamine out of the front of the brain. The fast version (Val/Val) clears it quickly, leaving less dopamine there at rest, and that group tends to notice the focus effect most. The slow version (Met/Met) leaves more dopamine in place already, so Semax on top can tip into feeling wired rather than sharp, particularly above 400 mcg. If this describes you, start at 100 mcg and only move up after confirming your sleep is undisturbed for 3 to 4 days.
A dopamine receptor gene called DRD2 is a secondary consideration: its lower-activity versions mean weaker dopamine signalling in the brain's reward and motivation circuits, and carriers more often describe Semax as a drive effect rather than a focus effect. For the same genetic ground covered from a different compound's angle, the Dihexa guide goes through how these variants play out there.
One useful thing to rule out: Semax is broken down by enzymes in the blood that chop up peptides, not by the liver enzymes that handle most drugs. Liver-metabolism genetics therefore have nothing to say about how long Semax works, and any vendor telling you otherwise is selling you a test that cannot answer the question. Check your Semax peptide profile for what your data does cover.
Verdict
Semax has more published human trial data behind it than most focus peptides in common use. The dosage math is simple once you know your concentration: 100 to 200 mcg to start, 200 to 600 mcg as a standard cognitive dose, all using the 0.1% solution only. Never use the 1% clinical formulation for cognitive purposes. Cycle 10 to 14 days on and off. Where you sit on the BDNF and dopamine-clearance variants above is a reasonable guide to which end of the dose range to start on, not a prediction of how you will respond. If anxiety or stress management is your primary goal rather than focus and cognitive output, read the Semax vs Selank comparison before committing to a protocol. To find out whether Semax ranks in your top peptides based on your actual DNA, upload your existing genetic data or order a kit for a full personalized peptide report.
Frequently asked questions
How many mcg of Semax should I take per day?
The effective range for cognitive enhancement established in the Kaplan et al. 1996 double-blind human trial was 0.25 to 1.0 mg (250 to 1,000 mcg) per day as a single dose. Most users find 200 to 400 mcg as the practical sweet spot. If you are starting out, begin at 100 to 200 mcg and only titrate up after a full week of tolerance assessment.
What is the difference between Semax 0.1% and Semax 1%?
The 0.1% solution delivers 100 mcg per spray and is the standard formulation for cognitive enhancement. The 1% solution delivers 1,000 mcg per spray and is the clinical concentration used in Russian acute stroke protocols at 12,000 to 18,000 mcg per day under inpatient supervision. These are not interchangeable. Applying dosing instructions written for one concentration to the other creates a 10x overdose or underdose.
How many sprays of Semax nasal spray should I take?
With a 0.1% solution delivering 100 mcg per spray, a standard cognitive dose is 2 to 6 sprays per day taken as a single morning dose. Most protocols use 2 to 4 sprays (200 to 400 mcg) total. Always verify your bottle concentration before calculating sprays, because the same spray count means completely different doses with a 0.1% versus 1% product.
Does Semax need to be cycled or can you take it every day?
Russian clinical protocols structured Semax as defined courses: 10 to 14 days on, followed by equivalent breaks. The post-stroke rehabilitation data used two 10-day courses separated by a 20-day interval. Continuous use past 14 days without a break typically produces diminishing returns as the BDNF upregulation response normalizes. A 2-week break usually restores the initial effect level.
How long does Semax take to work after taking it?
Most users report cognitive effects within 30 to 60 minutes of a morning dose. The Kaplan et al. 1996 trial documented effects lasting 20 to 24 hours after a single intranasal dose. The fast onset comes from direct olfactory nerve transport to the brain, which bypasses the blood-brain barrier entirely. This is also why the effect lasts far longer than the 2-minute plasma half-life would suggest.
Is Semax legal in the United States in 2026?
Semax is not FDA-approved and is not scheduled under the DEA, placing personal possession in a legal gray zone. As of April 2026, the FDA removed Semax from its restricted compounding list and scheduled a formal Pharmacy Compounding Advisory Committee review for July 24, 2026. If approved, licensed US compounding pharmacies could legally prescribe it for specific indications. Until that ruling, it is sold as a research chemical by gray-market vendors, which is not the same as legally approved.
What does Semax feel like when it works?
Users consistently describe increased verbal fluency, working memory, and task focus within 30 to 60 minutes of a morning dose. The effect is often compared to a clean stimulant without jitteriness or afternoon crash. Mood improvement often accompanies the cognitive sharpening, which fits the dopamine and serotonin effects seen in animal research. First-time users who clear dopamine slowly (the Met/Met version of the COMT enzyme) occasionally report feeling wired at higher doses, which usually resolves at 100 to 200 mcg.
This article is for informational and educational purposes only. It is not medical advice and does not diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before starting any peptide protocol. Individual results vary. Some outbound links are affiliate links, at no extra cost to you.